Individuals Discontinuing Slimming Medications Gain Back Weight Four Times Faster Than Dieters

Fresh analysis suggests that patients who stop using new slimming jabs like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who end conventional lifestyle regimens.

Findings released in a prominent health publication shows that while obese people can lose about a fifth of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.

"People using such treatments need to be cognizant of the risk of fast weight regain when the treatment is stopped," warns expert Dr. Susan Jebb.

That rate of recovery suggests a return to original mass in about a year and a half.

Comparing Therapies

The analysis, which looked at dozens of trials involving thousands of participants, contrasted the outcomes of the injectable medications with conventional dieting.

Scientists emphasize that individuals who shed pounds through dieting generally experience a slower creep back—around 100 grams monthly—post-intervention.

Understanding the Rapid Rebound

Doctors believe the mode of action of the drugs explains the accelerated rebound.

The injections mimic a natural hormone called glucagon-like peptide-1, which controls appetite.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the system to produce less of its own natural GLP-1, and could lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this hormone supplement means hunger is unsuppressed, making excessive eating much more probable."

A Lifelong Disease?

Health authorities advise the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.

Many experts say that, due to the high risk of weight regain, the treatment should be considered ongoing.

This perspective is reinforced by drug manufacturers, who state that the findings "underscore the persistent nature of excess weight," akin to managing conditions like hypertension.

User Testimonies

Users who have come off the jabs report a sudden return of cravings.

"It felt as if something flipping and you become starving," said a patient.

This difficulty is worsened if patients have not established sustainable dietary or behavioural modifications during therapy.

Growing Adoption

Survey data show that a significant number of adults in the UK have used these injections in the past year, with interest being substantial.

• Adoption is higher among women than males.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, researchers stress that while the jabs are effective agents for weight loss, they are not a standalone solution and maintained weight loss likely depends on ongoing lifestyle management.